---
title: "Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products | SLP Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283494231.md"
description: "Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products | SLP Stock News"
datetime: "2026-04-21T03:55:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283494231.md)
  - [en](https://longbridge.com/en/news/283494231.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283494231.md)
---

# Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products | SLP Stock News

Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products | SLP Stock News

### Related Stocks

- [SLP.US](https://longbridge.com/en/quote/SLP.US.md)
- [LZAGY.US](https://longbridge.com/en/quote/LZAGY.US.md)
- [O6Z.SG](https://longbridge.com/en/quote/O6Z.SG.md)

## Related News & Research

- [Simulations Plus CEO joins Craig-Hallum Institutional Investor Conference for one-on-one meetings](https://longbridge.com/en/news/287266278.md)
- [Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling | SLP Stock News](https://longbridge.com/en/news/280624523.md)
- [From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook](https://longbridge.com/en/news/287107112.md)
- [United Therapeutics CEO Martine Rothblatt disposes of USD 4.55 million in shares](https://longbridge.com/en/news/287270035.md)
- [12:00 ETVilla Albertine Announces the Lafayette Fellowship, a Prestigious New Graduate Scholarship in France for America's Emerging Leaders](https://longbridge.com/en/news/287248753.md)